Xianghua Huang
12PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Apr 01, 2026
B -Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor- T -Cell Therapy for Relapsed or Refractory AL Amyloidosis.Xianghua Huang, Xiaomei Wu, Wencui Chen
|Mar 10, 2026
Long-term outcomes of autologous stem cell transplantation for AL amyloidosis: a 15-year experience from a Chinese referral center and a comparison of different eras.Mengnan Liu, Jinzhou Guo, Wencui Chen
|Dec 26, 2025
Bortezomib combined with autologous stem cell transplantation overcomes cytogenetic abnormalities in AL amyloidosis.Yixuan Ren, Weiwei Xu, Jinzhou Guo
|Jul 17, 2025
Kidney disease after hematopoietic stem cell transplant-treatment standard.Yu Zhang, Weiwei Fu, Xianghua Huang
|Apr 01, 2025
The pre-ASCT serum albumin and pre-ASCT dFLC are prognostic markers in renal light chain amyloidosis patients treated with autologous stem cell transplantation.Wencui Chen, Yuanyuan Zhang, Jinzhou Guo
|Feb 19, 2025
Autologous hematopoietic stem cell transplantation for non-AL amyloidosis monoclonal gammopathy of renal significance.Mengnan Liu, Liang Zhao, Jinzhou Guo
Pageof 2
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
